中国实用外科杂志 ›› 2012, Vol. 32 ›› Issue (04): 298-300.
• 专题笔谈 • 上一篇 下一篇
师英强
出版日期:
发布日期:
Online:
Published:
摘要:
食管胃结合部腺癌(AEG)无论从发病机制还是生物学行为上,均不同于食管癌和胃癌,外科治疗时常需考虑是否行联合脏器切除术,尤其是脾脏切除。然而,行脾脏切除术对此类病人术后存活率的影响目前尚存在一定争议。因此,临床上行手术AEG治疗时,应首先明确肿瘤的不同分型、慎重考虑手术的难易程度、全面综合评估原发灶与脾脏的关系及脾门淋巴结的状态,再决定是否行联合脾脏等脏器切除术。
关键词: 食管胃结合部癌, 脾脏切除
Abstract:
The indication and efficacy evaluation of combined multiple organ resections in treating patients with adenocarcinoma of the esophagogastric junction SHI Ying-qiang. Department of Stomach and Soft Tissue Sarcoma Surgery, Shanghai Cancer Center, Fudan University, Shanghai 200032, China Abstract Adenocarcinoma of the esophagogastric junction (AEG), in terms of pathogenesis or biological characteristic, is different from esophageal cancer and gastric cancer. Whether need to perform combined multiple organ resections, especially splenectomy, should be considered when treating patients with AEG by surgery. However, there are some controversies about the postoperative survival rate of such patients performed splenectomy. Therefore, when treating such patients by surgery, different types of tumors should be ascertained and difficulty level of surgery should be considered. Furthermore, the relation of primary cancer and spleen as well as status of splenic hilus lymph node should be evaluated comprehensively. Thereafter, it is proper to decide whether combined splenectomy should be performed.
Key words: adenocarcinoma of esophagogastric junction, splenectomy
师英强. 食管胃结合部腺癌行联合脏器切除指征及疗效评价[J]. 中国实用外科杂志, 2012, 32(04): 298-300.
0 / 推荐
导出引用管理器 EndNote|Ris|BibTeX
链接本文: https://www.zgsyz.com/zgsywk/CN/
https://www.zgsyz.com/zgsywk/CN/Y2012/V32/I04/298